Plasma glutamine concentration in spinal cord injured patients

被引:16
作者
Rogeri, PS
Rosa, LFBPC
机构
[1] Univ Sao Paulo, Dept Histol & Embryol, Inst Ciencias Biomed 1, BR-05508900 Sao Paulo, Brazil
[2] Univ Sao Paulo, Inst Biomed Sci, Lab Metab, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
glutamine; cytokines; tumour necrosis factor; interleukin-1; glutamate; spinal cord injury;
D O I
10.1016/j.lfs.2004.09.050
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Glutamine, a non-essential amino acid, is the most important source of energy for macrophages and lymphocytes. Reduction in its plasma concentration is related with loss of immune function, as leukocyte proliferation and cytokine production. It is well known that glutamine is largely produced by the skeletal muscle which is severely compromised as a consequence of the paralysis due to the damage of the spinal cord. In spinal cord injury (SCI) patients, infections, such as pneumonia and sepsis in general, are a major cause of morbidity and mortality. In comparison with the control group, a 54% decrease in plasma glutamine concentration was observed as well as a decrease in the production of TNF and IL-1 by peripheral blood mononuclear cells cultivated for 48 h in SCI patients. Therefore, we propose that a decrease in plasma glutamine concentration is an important contributor to the immunosuppression seen in SCI patients. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:2351 / 2360
页数:10
相关论文
共 41 条
[1]
Effects of glutamine on immune cells [J].
Abcouwer, SF .
NUTRITION, 2000, 16 (01) :67-69
[2]
BEHAVIORALLY CONDITIONED IMMUNOSUPPRESSION AND MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ADER, R ;
COHEN, N .
SCIENCE, 1982, 215 (4539) :1534-1536
[3]
ARDAWI MSM, 1985, ESSAYS BIOCHEM, V21, P1
[4]
Critical care of spinal cord injury [J].
Ball, PA .
SPINE, 2001, 26 (24) :S27-S30
[5]
Branched-chain amino acid supplementation and the immune response of long-distance athletes [J].
Bassit, RA ;
Sawada, LA ;
Bacurau, RFP ;
Navarro, F ;
Martins, E ;
Santos, RVT ;
Caperuto, EC ;
Rogeri, P ;
Rosa, LFBP .
NUTRITION, 2002, 18 (05) :376-379
[6]
Bernt E., 1974, METHOD ENZYMAT AN, P1704, DOI [10.1016/B978-0-12-091304-6.50017-3, DOI 10.1016/B978-0-12-091304-6.50017-3]
[7]
Botterell E H, 1975, Can J Neurol Sci, V2, P361
[8]
Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury - Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial [J].
Bracken, MB ;
Shepard, MJ ;
Holford, TR ;
LeoSummers, L ;
Aldrich, EF ;
Fazl, M ;
Fehlings, M ;
Herr, DL ;
Hitchon, PW ;
Marshall, LF ;
Nockels, RP ;
Pascale, V ;
Perot, PL ;
Piepmeier, J ;
Sonntag, VKH ;
Wagner, F ;
Wilberger, JE ;
Winn, HR ;
Young, W .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (20) :1597-1604
[9]
Establishing prognosis and maximizing functional outcomes after spinal cord injury - A review of current and future directions in rehabilitation management [J].
Burns, AS ;
Ditunno, JF .
SPINE, 2001, 26 (24) :S137-S145
[10]
ALTERATION OF IMMUNE-SYSTEM FUNCTION IN TETRAPLEGICS - A PILOT-STUDY [J].
CAMPAGNOLO, DI ;
KELLER, SE ;
DELISA, JA ;
GLICK, TJ ;
SIPSKI, ML ;
SCHLEIFER, SJ .
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 1994, 73 (06) :387-393